Switzerland· 68545001

Decitabine Ideogen

A decitabine product containing decitabinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01BC08

Checked against BAG Spezialitätenliste (Switzerland) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about decitabinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Decitabine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01BC08 (decitabine), each read from that country’s own register.

This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
8 of them publish a price we can compare per daily dose

Search decitabine products by name

Decitabine · ATC L01BC08

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of decitabine costs, country by country.

Normalised to the WHO defined daily dose (6.43 mg), so markets compare like for like.

Switzerland: $137.43 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Decitabine · price per daily dose (6.43 mg)

USD · FX 28 Sept 2026

CH Switzerland$137.43

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)

Active substance: decitabinum
Manufacturer: —
Country: Switzerland (CH)
ATC code: L01BC08
ATC class: Decitabine
Defined daily dose: 6.43 mg, P
Swissmedic category: A
Reimbursed: Yes
Source register: BAG Spezialitätenliste (Switzerland)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

gtin
7680685450012
Durchstf 1 Stk
CHF 777.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

112 interactions on record for decitabine.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check decitabine against other medicines How interaction checks work

Decitabine · interactions on record

112 records

30 severe
82 moderate

Most severe, free to view

CladribineL01BB04severe
Talimogene laherparepvecL01XL02severe
Talimogen laherparepvecL01XX51severe
LeflunomidL04AA13severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Decitabine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All decitabine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Decitabin Accord, Decitabine Ever Pharma
Belgium · Decitabine Ever Pharma, Decitabine Hikma
Bulgaria · Децитабин Ever Pharma
Cyprus · Decitabine Accord, Decitabine Teva
Denmark · Decitabin Teva, Decitabine "sandoz"
Spain · Decitabina Accord, Decitabina Eugia
Finland · Decitabine Ever Pharma
United Kingdom (Northern Ireland) · Decitabine Hikma Farmacêutica (Portugal)
Croatia · Decitabin Accord, Decitabine Ever Pharma
Hungary · Decitabine Ever Pharma
Ireland · Decitabine Accord, Decitabine Ever Pharma
Iceland · Dacogen
Italy · Decitabina Accord, Decitabina Aurobindo
Liechtenstein · Dacogen
Lithuania · Decitabine Accord, Decitabine Ever Pharma
Latvia · Decitabine Ever Pharma
Netherlands · Decitabine Ever Pharma, Decitabine Hikma
Norway · Dacogen, Decitabin Teva
Portugal · Decitabina Accord, Decitabina Eugia
Romania · Decitabină Accord, Decitabină Sandoz
Sweden · Decitabin Teva, Decitabine Accord
Slovenia · Decitabin Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b4241c96-b7ef-4937-acad-d54902149a46
GET /v1/drugs/b4241c96-b7ef-4937-acad-d54902149a46?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "decitabinum 50 mg",
  "valid_from": "2024-11-01",
  "limitations": "[{\"description\":\"Für die Behandlung erwachsener Patienten mit akuter myeloischer Leukämie (AML), für welche eine intensive Chemotherapie und/oder Stammzelltransplantation nicht in Frage kommen.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"21846.02\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2024-11-01\",\"validTo\":null}]",
  "galenic_form": "Trockensub 50 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2024-11-01",
  "self_retention_pct": 10
}

API reference MCP server Plans

See everything about decitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console